 | • レポートコード：MRC2312MG16098 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、60ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のプレシジョンオンコロジー市場規模と予測を収録しています。・世界のプレシジョンオンコロジー市場：売上、2018年-2023年、2024年-2029年 ・世界のプレシジョンオンコロジー市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のプレシジョンオンコロジー市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「診断」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 プレシジョンオンコロジーのグローバル主要企業は、Acrivon Therapeutics、 Bio-Serv、 Exact Sciences Corporation、 Illumina, Inc.、 Invitae Corporation、 Laboratory Corporation of America、 QIAGEN、 Rain Oncology、 Relay Therapeutics、 Strata Oncology, Inc.、 Thermo Fisher Scientific Inc.、 Variantyx, Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、プレシジョンオンコロジーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のプレシジョンオンコロジー市場：タイプ別、2018年-2023年、2024年-2029年 世界のプレシジョンオンコロジー市場：タイプ別市場シェア、2022年 ・診断、治療 世界のプレシジョンオンコロジー市場：用途別、2018年-2023年、2024年-2029年 世界のプレシジョンオンコロジー市場：用途別市場シェア、2022年 ・製薬＆バイオテクノロジー企業、病院＆診断研究所、医療データ企業 世界のプレシジョンオンコロジー市場：地域・国別、2018年-2023年、2024年-2029年 世界のプレシジョンオンコロジー市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるプレシジョンオンコロジーのグローバル売上、2018年-2023年 ・主要企業におけるプレシジョンオンコロジーのグローバル売上シェア、2022年 ・主要企業におけるプレシジョンオンコロジーのグローバル販売量、2018年-2023年 ・主要企業におけるプレシジョンオンコロジーのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Acrivon Therapeutics、 Bio-Serv、 Exact Sciences Corporation、 Illumina, Inc.、 Invitae Corporation、 Laboratory Corporation of America、 QIAGEN、 Rain Oncology、 Relay Therapeutics、 Strata Oncology, Inc.、 Thermo Fisher Scientific Inc.、 Variantyx, Inc. ************************************************************* ・調査・分析レポートの概要 プレシジョンオンコロジー市場の定義 市場セグメント 世界のプレシジョンオンコロジー市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のプレシジョンオンコロジー市場規模 世界のプレシジョンオンコロジー市場規模：2022年 VS 2029年 世界のプレシジョンオンコロジー市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのプレシジョンオンコロジーの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のプレシジョンオンコロジー製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：診断、治療 プレシジョンオンコロジーのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬＆バイオテクノロジー企業、病院＆診断研究所、医療データ企業 プレシジョンオンコロジーの用途別グローバル売上・予測 ・地域別市場分析 地域別プレシジョンオンコロジー市場規模 2022年と2029年 地域別プレシジョンオンコロジー売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Acrivon Therapeutics、 Bio-Serv、 Exact Sciences Corporation、 Illumina, Inc.、 Invitae Corporation、 Laboratory Corporation of America、 QIAGEN、 Rain Oncology、 Relay Therapeutics、 Strata Oncology, Inc.、 Thermo Fisher Scientific Inc.、 Variantyx, Inc. ... |
This research report provides a comprehensive analysis of the Precision Oncology market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Precision Oncology market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Precision Oncology, challenges faced by the industry, and potential opportunities for market players.
The global Precision Oncology market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Precision Oncology market presents opportunities for various stakeholders, including Pharmaceutical＆Biotechnology Companies, Hospitals＆Diagnostic Laboratories. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Precision Oncology market. Additionally, the growing consumer demand present avenues for market expansion.
The global Precision Oncology market was valued at US$ 90070 million in 2022 and is projected to reach US$ 178800 million by 2029, at a CAGR of 10.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Precision oncology has led to significant advances in cancer treatment, particularly in the treatment of rare and hard-to-treat cancers. It has helped reduce the side effects of cancer treatment by minimizing the use of chemotherapy and other treatments that may not be effective for a particular patient’s tumor.
Key Features:
The research report on the Precision Oncology market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Precision Oncology market.
Market Overview: The report provides a comprehensive overview of the Precision Oncology market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Diagnostics, Therapeutics), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Precision Oncology market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Precision Oncology market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Precision Oncology market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Precision Oncology market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Precision Oncology market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Precision Oncology market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Precision Oncology, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Precision Oncology market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Precision Oncology market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Diagnostics
Therapeutics
Market segment by Application
Pharmaceutical＆Biotechnology Companies
Hospitals＆Diagnostic Laboratories
Healthcare Data Companies
Global Precision Oncology Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East＆Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East＆Africa
Major players covered
Acrivon Therapeutics
Bio-Serv
Exact Sciences Corporation
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America
QIAGEN
Rain Oncology
Relay Therapeutics
Strata Oncology, Inc.
Thermo Fisher Scientific Inc.
Variantyx, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Oncology, market overview.
Chapter 2: Global Precision Oncology market size in revenue.
Chapter 3: Detailed analysis of Precision Oncology company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Oncology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research＆Analysis Reports
1.1 Precision Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Oncology Market Overview
1.4 Features＆Benefits of This Report
1.5 Methodology＆Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions＆Caveats
2 Global Precision Oncology Overall Market Size
2.1 Global Precision Oncology Market Size: 2022 VS 2029
2.2 Global Precision Oncology Market Size, Prospects＆Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities＆Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Oncology Players in Global Market
3.2 Top Global Precision Oncology Companies Ranked by Revenue
3.3 Global Precision Oncology Revenue by Companies
3.4 Top 3 and Top 5 Precision Oncology Companies in Global Market, by Revenue in 2022
3.5 Global Companies Precision Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Oncology Players in Global Market
3.6.1 List of Global Tier 1 Precision Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Precision Oncology Market Size Markets, 2022＆2029
4.1.2 Diagnostics
4.1.3 Therapeutics
4.2 By Type – Global Precision Oncology Revenue＆Forecasts
4.2.1 By Type – Global Precision Oncology Revenue, 2018-2023
4.2.2 By Type – Global Precision Oncology Revenue, 2024-2029
4.2.3 By Type – Global Precision Oncology Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Precision Oncology Market Size, 2022＆2029
5.1.2 Pharmaceutical＆Biotechnology Companies
5.1.3 Hospitals＆Diagnostic Laboratories
5.1.4 Healthcare Data Companies
5.2 By Application – Global Precision Oncology Revenue＆Forecasts
5.2.1 By Application – Global Precision Oncology Revenue, 2018-2023
5.2.2 By Application – Global Precision Oncology Revenue, 2024-2029
5.2.3 By Application – Global Precision Oncology Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Precision Oncology Market Size, 2022＆2029
6.2 By Region – Global Precision Oncology Revenue＆Forecasts
6.2.1 By Region – Global Precision Oncology Revenue, 2018-2023
6.2.2 By Region – Global Precision Oncology Revenue, 2024-2029
6.2.3 By Region – Global Precision Oncology Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Precision Oncology Revenue, 2018-2029
6.3.2 US Precision Oncology Market Size, 2018-2029
6.3.3 Canada Precision Oncology Market Size, 2018-2029
6.3.4 Mexico Precision Oncology Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Precision Oncology Revenue, 2018-2029
6.4.2 Germany Precision Oncology Market Size, 2018-2029
6.4.3 France Precision Oncology Market Size, 2018-2029
6.4.4 U.K. Precision Oncology Market Size, 2018-2029
6.4.5 Italy Precision Oncology Market Size, 2018-2029
6.4.6 Russia Precision Oncology Market Size, 2018-2029
6.4.7 Nordic Countries Precision Oncology Market Size, 2018-2029
6.4.8 Benelux Precision Oncology Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Precision Oncology Revenue, 2018-2029
6.5.2 China Precision Oncology Market Size, 2018-2029
6.5.3 Japan Precision Oncology Market Size, 2018-2029
6.5.4 South Korea Precision Oncology Market Size, 2018-2029
6.5.5 Southeast Asia Precision Oncology Market Size, 2018-2029
6.5.6 India Precision Oncology Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Precision Oncology Revenue, 2018-2029
6.6.2 Brazil Precision Oncology Market Size, 2018-2029
6.6.3 Argentina Precision Oncology Market Size, 2018-2029
6.7 Middle East＆Africa
6.7.1 By Country – Middle East＆Africa Precision Oncology Revenue, 2018-2029
6.7.2 Turkey Precision Oncology Market Size, 2018-2029
6.7.3 Israel Precision Oncology Market Size, 2018-2029
6.7.4 Saudi Arabia Precision Oncology Market Size, 2018-2029
6.7.5 UAE Precision Oncology Market Size, 2018-2029
7 Precision Oncology Companies Profiles
7.1 Acrivon Therapeutics
7.1.1 Acrivon Therapeutics Company Summary
7.1.2 Acrivon Therapeutics Business Overview
7.1.3 Acrivon Therapeutics Precision Oncology Major Product Offerings
7.1.4 Acrivon Therapeutics Precision Oncology Revenue in Global Market (2018-2023)
7.1.5 Acrivon Therapeutics Key News＆Latest Developments
7.2 Bio-Serv
7.2.1 Bio-Serv Company Summary
7.2.2 Bio-Serv Business Overview
7.2.3 Bio-Serv Precision Oncology Major Product Offerings
7.2.4 Bio-Serv Precision Oncology Revenue in Global Market (2018-2023)
7.2.5 Bio-Serv Key News＆Latest Developments
7.3 Exact Sciences Corporation
7.3.1 Exact Sciences Corporation Company Summary
7.3.2 Exact Sciences Corporation Business Overview
7.3.3 Exact Sciences Corporation Precision Oncology Major Product Offerings
7.3.4 Exact Sciences Corporation Precision Oncology Revenue in Global Market (2018-2023)
7.3.5 Exact Sciences Corporation Key News＆Latest Developments
7.4 Illumina, Inc.
7.4.1 Illumina, Inc. Company Summary
7.4.2 Illumina, Inc. Business Overview
7.4.3 Illumina, Inc. Precision Oncology Major Product Offerings
7.4.4 Illumina, Inc. Precision Oncology Revenue in Global Market (2018-2023)
7.4.5 Illumina, Inc. Key News＆Latest Developments
7.5 Invitae Corporation
7.5.1 Invitae Corporation Company Summary
7.5.2 Invitae Corporation Business Overview
7.5.3 Invitae Corporation Precision Oncology Major Product Offerings
7.5.4 Invitae Corporation Precision Oncology Revenue in Global Market (2018-2023)
7.5.5 Invitae Corporation Key News＆Latest Developments
7.6 Laboratory Corporation of America
7.6.1 Laboratory Corporation of America Company Summary
7.6.2 Laboratory Corporation of America Business Overview
7.6.3 Laboratory Corporation of America Precision Oncology Major Product Offerings
7.6.4 Laboratory Corporation of America Precision Oncology Revenue in Global Market (2018-2023)
7.6.5 Laboratory Corporation of America Key News＆Latest Developments
7.7 QIAGEN
7.7.1 QIAGEN Company Summary
7.7.2 QIAGEN Business Overview
7.7.3 QIAGEN Precision Oncology Major Product Offerings
7.7.4 QIAGEN Precision Oncology Revenue in Global Market (2018-2023)
7.7.5 QIAGEN Key News＆Latest Developments
7.8 Rain Oncology
7.8.1 Rain Oncology Company Summary
7.8.2 Rain Oncology Business Overview
7.8.3 Rain Oncology Precision Oncology Major Product Offerings
7.8.4 Rain Oncology Precision Oncology Revenue in Global Market (2018-2023)
7.8.5 Rain Oncology Key News＆Latest Developments
7.9 Relay Therapeutics
7.9.1 Relay Therapeutics Company Summary
7.9.2 Relay Therapeutics Business Overview
7.9.3 Relay Therapeutics Precision Oncology Major Product Offerings
7.9.4 Relay Therapeutics Precision Oncology Revenue in Global Market (2018-2023)
7.9.5 Relay Therapeutics Key News＆Latest Developments
7.10 Strata Oncology, Inc.
7.10.1 Strata Oncology, Inc. Company Summary
7.10.2 Strata Oncology, Inc. Business Overview
7.10.3 Strata Oncology, Inc. Precision Oncology Major Product Offerings
7.10.4 Strata Oncology, Inc. Precision Oncology Revenue in Global Market (2018-2023)
7.10.5 Strata Oncology, Inc. Key News＆Latest Developments
7.11 Thermo Fisher Scientific Inc.
7.11.1 Thermo Fisher Scientific Inc. Company Summary
7.11.2 Thermo Fisher Scientific Inc. Business Overview
7.11.3 Thermo Fisher Scientific Inc. Precision Oncology Major Product Offerings
7.11.4 Thermo Fisher Scientific Inc. Precision Oncology Revenue in Global Market (2018-2023)
7.11.5 Thermo Fisher Scientific Inc. Key News＆Latest Developments
7.12 Variantyx, Inc.
7.12.1 Variantyx, Inc. Company Summary
7.12.2 Variantyx, Inc. Business Overview
7.12.3 Variantyx, Inc. Precision Oncology Major Product Offerings
7.12.4 Variantyx, Inc. Precision Oncology Revenue in Global Market (2018-2023)
7.12.5 Variantyx, Inc. Key News＆Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer